The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerguson Regulatory News (FERG)

Share Price Information for Ferguson (FERG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17,510.00
Bid: 17,515.00
Ask: 17,540.00
Change: -25.00 (-0.14%)
Spread: 25.00 (0.143%)
Open: 17,610.00
High: 17,690.00
Low: 17,495.00
Prev. Close: 17,535.00
FERG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Ferguson plc: Share Repurchase Program

9 Oct 2023 07:00

Ferguson plc (the "Company") announces that, in continuation of its $3.0 billion share repurchase program (the "Program"), it has entered into a non-discretionary arrangement with its broker J.P. Morgan Securities LLC (“JPMS”) commencing from October 9, 2023 and ending no later than December 15, 2023. JPMS, an independent third party, will make trading decisions concerning the timing of the purchases of the Company's shares independently of the Company. JPMS will carry out the instruction through the acquisition by JPMS, as agent on behalf of the Company, of ordinary shares in the Company.

The maximum pecuniary amount allocated to this tranche of the Program is $130 million. The value of shares repurchased by the Company under the Program pursuant to the various arrangements entered into with its brokers will not, in aggregate, exceed $3.0 billion.

The Company's shareholders generally authorized the Company to purchase up to a maximum of 20,845,062 of its ordinary shares at its Annual General Meeting held on November 30, 2022. Pursuant to such authority, the Company intends to continue purchasing shares under the Program. The Company anticipates that it will request a similar general authority from shareholders at its 2023 Annual General Meeting to be held in November 2023 pursuant to which (to the extent the Program has not been completed by then) purchases of shares under the Program will continue. The aggregate number of shares acquired under such authority by the Company pursuant to the Program shall not exceed the maximum number of shares which the Company is authorized to purchase pursuant to such general authority. It is intended that any shares repurchased under the Program will be transferred into treasury.

The purpose of the Program is to reduce the capital of the Company. To the extent required, the Company may in the future use the repurchased shares to satisfy share awards. Any purchases of shares by the Company in relation to this tranche of the Program will be carried out on the New York Stock Exchange (in accordance with the terms of the arrangement entered into with JPMS) and in accordance with (and subject to the limits prescribed by) the Company's general authority to repurchase shares granted by its shareholders, the Market Abuse Regulation 596/2014 (as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018), Rule 10b5-1 and Rule 10b-18 under the U.S. Securities Exchange Act of 1934, as amended.

About Ferguson plc

Ferguson plc (NYSE: FERG; LSE: FERG) is a leading value-added distributor in North America providing expertise, solutions and products from infrastructure, plumbing and appliances to HVAC, fire, fabrication and more. We exist to make our customers' complex projects simple, successful and sustainable. Ferguson is headquartered in the U.K., with its operations and associates solely focused on North America and managed from Newport News, Virginia. For more information, please visit corporate.ferguson.com or follow us on LinkedIn linkedin.com/company/ferguson-enterprises.

Cautionary note regarding forward-looking statements

Certain information in this announcement is forward-looking within the meaning of the United States Private Securities Litigation Reform Act of 1995, including with relation to our share repurchase program and its purpose and timetable. Forward-looking statements cover all matters which are not historical facts and speak only as of the date on which they are made. Forward-looking statements can be identified by the use of forward-looking terminology such as "will," "intend," “expect,” “anticipate,” or other variations or comparable terminology. Many factors could cause actual results to differ materially from those in such forward-looking statements, including, but not limited to: weakness in the economy, market trends, uncertainty and other conditions in the markets in which we operate, and other factors beyond our control, including disruption in the financial markets and any macroeconomic or other consequences of the current conflict in Ukraine or potential conflict between China and Taiwan; failure to rapidly identify or effectively respond to direct and/or end customers' wants, expectations or trends, including costs and potential problems associated with new or upgraded information technology systems or our ability to timely deploy new omni-channel capabilities; unsuccessful execution of our operational strategies; adverse impacts caused by a public health crisis; and other risks and uncertainties set forth under the heading "Risk Factors" in our Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on September 26, 2023, and in other filings we make with the SEC in the future. Forward-looking statements regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. Other than in accordance with our legal or regulatory obligations we undertake no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

For further information please contact: Investor Inquiries Brian Lantz Vice President, IR and Communications +1 224 285 2410 Pete Kennedy Director, Investor Relations +1 757 603 0111 Media Inquiries Christine Dwyer Senior Director, Communications +1 757 469 5813

View source version on businesswire.com: https://www.businesswire.com/news/home/20231008587140/en/

Copyright Business Wire 2023

Date   Source Headline
7th Apr 20217:00 amRNSTransaction in Own Shares
6th Apr 20217:00 amRNSTransaction in Own Shares
1st Apr 20217:00 amRNSTotal Voting Rights
1st Apr 20217:00 amRNSTransaction in Own Shares
31st Mar 20217:00 amRNSTransaction in Own Shares
30th Mar 20217:00 amRNSTransaction in Own Shares
29th Mar 20217:00 amRNSTransaction in Own Shares
26th Mar 20217:00 amRNSTransaction in Own Shares
25th Mar 20217:00 amRNSTransaction in Own Shares
24th Mar 20217:00 amRNSTransaction in Own Shares
22nd Mar 20216:20 pmRNSTransaction in Own Shares
22nd Mar 202111:45 amRNSDirector/PDMR Shareholding
22nd Mar 20217:00 amRNSShare buy back program
16th Mar 20217:00 amRNSResults for the half year ended January 31, 2021
15th Mar 202112:45 pmRNSDirector/PDMR Shareholding
12th Mar 202110:45 amRNSDirector/PDMR Shareholding
11th Mar 202111:45 amRNSDirector/PDMR Shareholding
8th Mar 20217:00 amRNSAdditional US listing effective today
2nd Mar 202111:00 amRNSNotice of Results
26th Feb 20212:32 pmRNSTotal Voting Rights
3rd Feb 20217:00 amRNSUpdate on additional US listing
1st Feb 20217:00 amRNSCompletion of Wolseley UK disposal
29th Jan 20213:11 pmRNSTotal Voting Rights
22nd Jan 20219:30 amRNSDirector/PDMR Shareholding
4th Jan 20217:00 amRNSDisposal of Wolseley UK
31st Dec 202011:10 amRNSTotal Voting Rights
30th Dec 202010:15 amRNSDirector/PDMR Shareholding
21st Dec 20209:00 amRNSNon-Executive Director Appointments
16th Dec 20201:00 pmRNSDirector/PDMR Shareholding
8th Dec 20207:00 amRNSTrading update for 3 months to October 31, 2020
4th Dec 20209:00 amRNSNotice of Dividend Currency Exchange Rate
3rd Dec 202011:47 amRNSResult of AGM
30th Nov 20203:05 pmRNSTotal Voting Rights
24th Nov 202011:30 amRNSNotice of Results
17th Nov 20202:00 pmRNSFerguson acquires Old Dominion and ACF
4th Nov 20202:45 pmRNSDirector/PDMR Shareholding
3rd Nov 202012:00 pmRNSDirector/PDMR Shareholding
30th Oct 20203:19 pmRNSBlock listing Interim Review
30th Oct 20203:17 pmRNSTotal Voting Rights
30th Oct 20202:00 pmRNSAnnual Financial Report
20th Oct 202012:07 pmRNSDirector/PDMR Shareholding
30th Sep 20203:09 pmRNSTotal Voting Rights
30th Sep 202012:00 pmRNSDirector/PDMR Shareholding
29th Sep 20209:00 amRNSAudit and Remuneration Committee Membership
29th Sep 20207:00 amRNSAppointment of Bill Brundage as Group CFO
29th Sep 20207:00 amRNSResults for the year ended July 31, 2020
15th Sep 202011:00 amRNSNotice of Results
1st Sep 202011:01 amRNSTotal Voting Rights
31st Jul 20203:08 pmRNSTotal Voting Rights
29th Jul 20201:31 pmRNSResult of Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.